I think their early focus on MDMA compared to psilocybin is strategic - there is better high quality data at this stage which is favourable when put to ethics committees. I think more likely to find TGA approval as well - there’s no guarantee come December that the TGA will down schedule both (if any).
- Forums
- ASX - By Stock
- EMD news articles
I think their early focus on MDMA compared to psilocybin is...
-
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.08M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.4¢ | $6.123K | 113.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 45385 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8388 | 0.054 |
2 | 129887 | 0.053 |
2 | 130000 | 0.050 |
1 | 70000 | 0.046 |
1 | 100000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 101282 | 2 |
0.057 | 17500 | 1 |
0.058 | 29000 | 1 |
0.059 | 250000 | 1 |
0.060 | 129899 | 5 |
Last trade - 11.31am 10/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online